Literature DB >> 27422241

Effects of state-level medicaid policies and patient characteristics on time to breast cancer surgery among medicaid beneficiaries.

Michael T Halpern1,2, Deborah Schrag3.   

Abstract

Medicaid beneficiaries with cancer are less likely to receive timely and high-quality care. This study examined whether differences in state-level Medicaid policies affect delays in time to surgery (TTS) among women diagnosed with breast cancer. Using 2006-2008 Medicaid data, we identified women aged 18-64 enrolled in Medicaid diagnosed with breast cancer. Analyses examined associations of state-specific Medicaid surgery reimbursements, Medicaid eligibility recertification period (annually vs. shorter) and required patient copayment on time from breast cancer diagnosis to receipt of breast surgery. Patients receiving neoadjuvant therapy were excluded. Separate multivariable regression analyses controlling for patient demographic characteristics and clustering by state were performed for breast conserving surgery (BCS), inpatient mastectomy, and outpatient mastectomy. The study included 7542 Medicaid beneficiaries with breast cancer: 3272 received BCS, 2156 outpatient mastectomy, and 2115 inpatient mastectomy. Higher Medicaid reimbursements for BCS were associated with decreased time from diagnosis to surgery. A 12-month (vs. <12 month) Medicaid eligibility recertification period was associated with decreased TTS for BCS and outpatient mastectomy. Black Medicaid beneficiaries (compared with non-Hispanic White beneficiaries) were more likely to experience delays for all three types of surgery, while Hispanic beneficiaries were more likely to experience delays only for outpatient mastectomy. State-level Medicaid policies and patient characteristics can affect receipt of timely surgery among Medicaid beneficiaries with breast cancer. As delays in surgery can increase morbidity and mortality, changes to state Medicaid policies and health system programs are needed to improve access to care for this vulnerable population.

Entities:  

Keywords:  Breast conserving surgery; Breast neoplasms; Mastectomy; Medicaid; Time factors

Mesh:

Year:  2016        PMID: 27422241     DOI: 10.1007/s10549-016-3879-8

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  6 in total

1.  Racial Differences in Time to Breast Cancer Surgery and Overall Survival in the US Military Health System.

Authors:  Yvonne L Eaglehouse; Matthew W Georg; Craig D Shriver; Kangmin Zhu
Journal:  JAMA Surg       Date:  2019-03-20       Impact factor: 14.766

2.  Race and delays in breast cancer treatment across the care continuum in the Carolina Breast Cancer Study.

Authors:  Katherine E Reeder-Hayes; Sophie E Mayer; Andrew F Olshan; Stephanie B Wheeler; Lisa A Carey; Chiu-Kit Tse; Mary Elizabeth Bell; Melissa A Troester
Journal:  Cancer       Date:  2019-08-09       Impact factor: 6.860

3.  Breast Cancer Disparities at Home and Abroad: A Review of the Challenges and Opportunities for System-Level Change.

Authors:  Katherine E Reeder-Hayes; Benjamin O Anderson
Journal:  Clin Cancer Res       Date:  2017-06-01       Impact factor: 12.531

4.  Integrating biology and access to care in addressing breast cancer disparities: 25 years' research experience in the Carolina Breast Cancer Study.

Authors:  Marc A Emerson; Katherine E Reeder-Hayes; Heather J Tipaldos; Mary E Bell; Marina R Sweeney; Lisa A Carey; H Shelton Earp; Andrew F Olshan; Melissa A Troester
Journal:  Curr Breast Cancer Rep       Date:  2020-05-14

5.  Association of Patient Demographic Characteristics and Insurance Status With Survival in Cancer Randomized Clinical Trials With Positive Findings.

Authors:  Joseph M Unger; Charles D Blanke; Michael LeBlanc; William E Barlow; Riha Vaidya; Scott D Ramsey; Dawn L Hershman
Journal:  JAMA Netw Open       Date:  2020-04-01

6.  County Rurality and Socioeconomic Deprivation Is Associated With Reduced Survival From Gastric Cancer in the United States.

Authors:  Robert J Huang; Shailja C Shah; M Constanza Camargo; Latha Palaniappan; Joo Ha Hwang
Journal:  Gastroenterology       Date:  2020-05-07       Impact factor: 22.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.